NEW YORK (GenomeWeb) – Biomax Informatics and Pierre Fabre, a French pharmaceutical company, are collaborating on the development of an integrated antibody sequence and knowledge database that will support Pierre Fabre's therapeutic antibody development efforts.
Using the BioXM Knowledge Management Environment, Biomax created the antibody knowledgebase, which offers sequence analysis and storage capabilities, infrastructure for sharing in-house data and algorithms, a collection of public data, and includes both public and third-party algorithms.
Following a successful pilot project, Pierre Fabre has licensed Biomax's BioXM Knowledge Management Environment and agreed to work with the company to further develop and expand the system.
Financial and other terms of the agreement were not disclosed.